Fabian F Pusch (Fabian Pusch)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Combination Therapy

Childhood Cancer

Top Venues

Molecular cancer therapeutics

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Fabian F Pusch, Heathcliff Dorado Garcia, Robin Xu, Dennis Gurgen, Yi Bei, Lotte Brueckner, Claudia Röefzaad, Jennifer von Stebut, Victor Bardinet, Rocio Chamorro González, Angelika Eggert, Johannes Hubertus Schulte, Patrick Hundsdörfer, Georg Seifert, Kerstin Haase, Beat W Schäfer, Marco Wachtel, Anja A Kühl, Michael V Ortiz, Antje M Wengner, Monika Scheer, Anton G Henssen
Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models. Molecular cancer therapeutics 23 (4) (2024)
Fabian F Pusch, Heathcliff Dorado Garcia, Robin Xu, Dennis Gurgen, Yi Bei, Lotte Brueckner, Claudia Röefzaad, Jennifer von Stebut, Victor Bardinet, Rocio Chamorro González, Angelika Eggert, Johannes Hubertus Schulte, Patrick Hundsdörfer, Georg Seifert, Kerstin Haase, Beat W Schäfer, Marco Wachtel, Anja A Kühl, Michael V Ortiz, Antje M Wengner, Monika Scheer, Anton G Henssen
Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models. Molecular cancer therapeutics 23 (4) (2024)
Fabian F Pusch, Heathcliff Dorado Garcia, Robin Xu, Dennis Gurgen, Yi Bei, Lotte Brueckner, Claudia Röefzaad, Jennifer von Stebut, Victor Bardinet, Rocio Chamorro González, Angelika Eggert, Johannes Hubertus Schulte, Patrick Hundsdörfer, Georg Seifert, Kerstin Haase, Beat W Schäfer, Marco Wachtel, Anja A Kühl, Michael V Ortiz, Antje M Wengner, Monika Scheer, Anton G Henssen
Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models. Molecular cancer therapeutics 23 (4) (2024)
Fabian F Pusch, Heathcliff Dorado Garcia, Robin Xu, Dennis Gurgen, Yi Bei, Lotte Brueckner, Claudia Röefzaad, Jennifer von Stebut, Victor Bardinet, Rocio Chamorro González, Angelika Eggert, Johannes Hubertus Schulte, Patrick Hundsdörfer, Georg Seifert, Kerstin Haase, Beat W Schäfer, Marco Wachtel, Anja A Kühl, Michael V Ortiz, Antje M Wengner, Monika Scheer, Anton G Henssen
Elimusertib has anti-tumor activity in preclinical patient-derived pediatric solid tumor models. Molecular cancer therapeutics (2023)
Fabian F Pusch, Heathcliff Dorado Garcia, Robin Xu, Dennis Gurgen, Yi Bei, Lotte Brueckner, Claudia Röefzaad, Jennifer von Stebut, Victor Bardinet, Rocio Chamorro González, Angelika Eggert, Johannes Hubertus Schulte, Patrick Hundsdörfer, Georg Seifert, Kerstin Haase, Beat W Schäfer, Marco Wachtel, Anja A Kühl, Michael V Ortiz, Antje M Wengner, Monika Scheer, Anton G Henssen
Elimusertib has anti-tumor activity in preclinical patient-derived pediatric solid tumor models. Molecular cancer therapeutics (2023)
Heathcliff Dorado Garcia, Fabian F Pusch, Yi Bei, Jennifer von Stebut, Glorymar Ibáñez, Kristina Guillan, Koshi Imami, Dennis Gürgen, Jana Rolff, Konstantin Helmsauer, Stephanie Meyer-Liesener, Natalie Timme, Victor Bardinet, Rocío Chamorro González, Ian C MacArthur, Celine Y Chen, Joachim Schulz, Antje M Wengner, Christian Furth, Birgit Lala, Angelika Eggert, Georg Seifert, Patrick Hundsoerfer, Marieluise Kirchner, Philipp Mertins, Matthias Selbach, Andrej Lissat, Frank Dubois, David Horst, Johannes Hubertus Schulte, Simone Spuler, Daoqi You, Filemon Dela Cruz, Andrew L Kung, Kerstin Haase, Michela Di Virgilio, Monika Scheer, Michael V Ortiz, Anton G Henssen
Therapeutic targeting of ATR in alveolar rhabdomyosarcoma. Nature communications 13 (1) (2022)